Minerva Neurosciences, Inc.
General ticker "NERV" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $29.9M (TTM average)
Minerva Neurosciences, Inc. follows the US Stock Market performance with the rate: 29.9%.
Estimated limits based on current volatility of 4.3%: low 3.94$, high 4.29$
Factors to consider:
- Total employees count: 7 (-12.5%) as of 2025
- Top business risk factors: Clinical trial failure, Regulatory and compliance, Operational and conduct risks, Capital raising, Manufacturing supply issues
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.73$, 8.08$]
- 2026-12-31 to 2027-12-31 estimated range: [2.00$, 6.01$]
Financial Metrics affecting the NERV estimates:
- Positive: with PPE of -2.1 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Inventory ratio change, % of 0 <= 0
Short-term NERV quotes
Long-term NERV plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $23.12MM | $21.85MM | $15.10MM |
| Operating Income | $-23.12MM | $-21.85MM | $-15.10MM |
| Non-Operating Income | $-6.89MM | $23.29MM | $-278.32MM |
| R&D Expense | $12.71MM | $11.90MM | $5.76MM |
| Income(Loss) | $-30.01MM | $1.44MM | $-293.42MM |
| Net Income(Loss)* | $-30.01MM | $1.44MM | $-293.42MM |
| Stockholders Equity | $-28.46MM | $-25.69MM | $-140.75MM |
| Assets | $56.90MM | $37.14MM | $97.97MM |
| Operating Cash Flow | $-14.78MM | $-19.55MM | $-13.51MM |
| Financing Cash Flow | $19.60MM | $0.00MM | $74.45MM |
| Earnings Per Share** | $-4.61 | $0.19 | $-34.67 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.